---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-25-000092"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:35:15.856989+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q2 revenue hits record $61.1M (+16% YoY); raises FY2025 guidance

## Summary
- Revenue of $61.1M (+16% YoY); domestic up 17%, international up 12%.
- Adjusted EBITDA $4.1M (+58% YoY); non-GAAP EPS improved to ($0.11) from ($0.23).
- Raised FY2025 revenue guidance to $237-242M from $236-242M; reaffirmed adjusted EBITDA $15-17M.
- Scoliosis revenue +35% to $18.5M; Trauma & Deformity +10% to $41.7M.
- OPSB expanded with new clinics, entry into Ireland for first international operation.

## SEC filing metadata
- accession: 0001425450-25-000092
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000092/0001425450-25-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000092/kids-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-25-000092
- JSON: https://secwatch.observer/filing/0001425450-25-000092.json
- Plain text: https://secwatch.observer/filing/0001425450-25-000092.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.